Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
Plos One|February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantRhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Use of multiepitope polyproteins in serodiagnosis of active tuberculosisRaymond L Houghton, Michael J Lodes, Davin C Dillon, et al.
Plos Neglected Tropical Diseases|September 22, 2010
Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasisSowmya Pattabhi, Jacqueline Whittle, Raodoh Mohamath, et al.
Clinical & Translational Immunology|December 20, 2016
A structure-function approach to optimizing TLR4 ligands for human vaccinesDarrick Carter, Christopher B Fox, Tracey A Day, et al.
Parasitology Research|April 15, 2014
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboonWeidong Zhang, Gul Ahmad, Loc Le, et al.
Nature Medicine|June 15, 2007
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorPatricia A Darrah, Dipti T Patel, Paula M De Luca, et al.
Vaccine|March 19, 2011
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasisJaya Chakravarty, Subodh Kumar, Sonali Trivedi, et al.
Clinical and Vaccine Immunology : CVI|December 18, 2009
Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosisMalcolm S Duthie, Marah N Hay, Cecile Z Morales, et al.
Journal of Virological Methods|August 25, 2017
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120Jae-Sung Yu, Hua-Xin Liao, Jamie Pritchett, et al.
Clinical and Vaccine Immunology : CVI|August 22, 2008
Selection of antigens and development of prototype tests for point-of-care leprosy diagnosisMalcolm S Duthie, Greg C Ireton, Ganga V Kanaujia, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
Plos One|February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantRhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Use of multiepitope polyproteins in serodiagnosis of active tuberculosisRaymond L Houghton, Michael J Lodes, Davin C Dillon, et al.
Plos Neglected Tropical Diseases|September 22, 2010
Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasisSowmya Pattabhi, Jacqueline Whittle, Raodoh Mohamath, et al.
Clinical & Translational Immunology|December 20, 2016
A structure-function approach to optimizing TLR4 ligands for human vaccinesDarrick Carter, Christopher B Fox, Tracey A Day, et al.
Parasitology Research|April 15, 2014
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboonWeidong Zhang, Gul Ahmad, Loc Le, et al.
Nature Medicine|June 15, 2007
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorPatricia A Darrah, Dipti T Patel, Paula M De Luca, et al.
Vaccine|March 19, 2011
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasisJaya Chakravarty, Subodh Kumar, Sonali Trivedi, et al.
Clinical and Vaccine Immunology : CVI|December 18, 2009
Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosisMalcolm S Duthie, Marah N Hay, Cecile Z Morales, et al.
Journal of Virological Methods|August 25, 2017
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120Jae-Sung Yu, Hua-Xin Liao, Jamie Pritchett, et al.
Clinical and Vaccine Immunology : CVI|August 22, 2008
Selection of antigens and development of prototype tests for point-of-care leprosy diagnosisMalcolm S Duthie, Greg C Ireton, Ganga V Kanaujia, et al.
Pageof 27